2024 annual financial data
Pacific Biosciences of California 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -133.79%.
Operating income was -474,313,000 USD and net income was -309,851,000 USD.
Operating cash flow was -206,058,000 USD.
Get free Pacific Biosciences of California email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 154,014,000 USD
- Operating income
- -474,313,000 USD
- Net income
- -309,851,000 USD
- Operating cash flow
- -206,058,000 USD